Crispr Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $64k | 30k | 2.13 |
| 2024-03-31 | $24k | 36k | 0.68 |
| 2018-12-31 | $638k | 22k | 28.59 |
| 2018-09-30 | $1.3M | 30k | 44.33 |